Generation Bio to Present at the 2024 TD Cowen Genetic Medicines & RNA Summit
Provided By GlobeNewswire
Last update: Jun 14, 2024
CAMBRIDGE, Mass., June 14, 2024 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO) a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced that Geoff McDonough, M.D., president and chief executive officer, will participate in a fireside chat at the virtual 2024 TD Cowen Genetic Medicines & RNA Summit on Friday, June 21st, 2024 at 1:50 p.m. ET.
0.3864
+0.01 (+3.62%)
Find more stocks in the Stock Screener
GBIO Latest News and Analysis
15 days ago - ChartmillGet insights into the top gainers and losers of Friday's after-hours session.The regular session of the US market on Friday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
